Cargando…

Multi-state model for predicting ocular progression in acute Stevens-Johnson syndrome/toxic epidermal necrolysis

This study aimed to clarify the etiologic factors predicting acute ocular progression in SJS/TEN, and identify patients who require immediate and intensive ophthalmological treatment. We previously conducted two Japanese Surveys of SJS/TEN (i.e., cases arising between 2005–2007 and between 2008–2010...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinoshita, Fumie, Yokota, Isao, Mieno, Hiroki, Ueta, Mayumi, Bush, John, Kinoshita, Shigeru, Sueki, Hirohiko, Asada, Hideo, Morita, Eishin, Fukushima, Masanori, Sotozono, Chie, Teramukai, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716030/ https://www.ncbi.nlm.nih.gov/pubmed/34941887 http://dx.doi.org/10.1371/journal.pone.0260730

Ejemplares similares

Japan: Diagnosis and Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications
por: Sotozono, Chie, et al.
Publicado: (2021)

Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic Eeidermal necrolysis
por: Yoshikawa, Yamato, et al.
Publicado: (2020)

Editorial: The Updated Understanding of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Kinoshita, Shigeru, et al.
Publicado: (2021)

Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
por: Saito, Kosuke, et al.
Publicado: (2016)

In Silico Risk Assessment of HLA-A*02:06-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Caused by Cold Medicine Ingredients
por: Isogai, Hideto, et al.
Publicado: (2013)

Challenges in the management of bilateral eyelid closure in Stevens-Johnson Syndrome
por: Aziza, Yulia, et al.
Publicado: (2022)

Downregulation of interferon-γ-induced protein 10 in the tears of patients with Stevens-Johnson syndrome with severe ocular complications in the chronic stage
por: Ueta, Mayumi, et al.
Publicado: (2017)

Long-Term Benefits of Tear Exchangeable Limbal-Rigid Contact Lens Wear Therapy in Stevens–Johnson Syndrome Cases
por: Yoshikawa, Yamato, et al.
Publicado: (2023)

Strong association between hla-a*02:06 and acetaminophen-related stevens-johnson syndrome with severe mucosal involvements in the Japanese
por: Ueta, Mayumi, et al.
Publicado: (2014)

Categorization of the Ocular Microbiome in Japanese Stevens–Johnson Syndrome Patients With Severe Ocular Complications
por: Ueta, Mayumi, et al.
Publicado: (2021)

Medication tendencies for inducing severe ocular surface symptoms in Japanese Stevens-Johnson Syndrome / toxic epidermal necrolysis patients
por: Saito, Yoshiro, et al.
Publicado: (2014)

Gene expression analysis of conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage
por: Ueta, Mayumi, et al.
Publicado: (2019)

HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese
por: Ueta, Mayumi, et al.
Publicado: (2008)

HLA association with antipyretic analgesics-induced Stevens-Johnson Syndrome / toxic epidermal necrolysis with severe ocular surface complications in japanese patients
por: Nakamura, Ryosuke, et al.
Publicado: (2014)

Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications
por: Ueta, Mayumi
Publicado: (2021)

Regulation of gene expression by miRNA-455-3p, upregulated in the conjunctival epithelium of patients with Stevens–Johnson syndrome in the chronic stage
por: Ueta, Mayumi, et al.
Publicado: (2020)

Mapping of susceptible variants for cold medicine-related Stevens–Johnson syndrome by whole-genome resequencing
por: Kawai, Yosuke, et al.
Publicado: (2021)

HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications
por: Ueta, Mayumi, et al.
Publicado: (2012)

Human leukocyte antigen B*0702 is protective against ocular Stevens–Johnson syndrome/toxic epidermal necrolysis in the UK population
por: Butt, Gibran F., et al.
Publicado: (2021)

Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens–Johnson syndrome with severe ocular complications in Japanese individuals
por: Ueta, Mayumi, et al.
Publicado: (2019)

Cold medicine-related Stevens–Johnson syndrome/toxic epidermal necrolysis with severe ocular complications–phenotypes and genetic predispositions
por: Ueta, Mayumi
Publicado: (2016)

Toxic epidermal necrolysis and Stevens-Johnson syndrome
por: Harr, Thomas, et al.
Publicado: (2010)

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
por: Klimas, Natasha, et al.
Publicado: (2015)

HLA-A*02:06 and PTGER3 polymorphism exert additive effects in cold medicine-related Stevens–Johnson syndrome with severe ocular complications
por: Ueta, Mayumi, et al.
Publicado: (2015)

Association of IKZF1 SNPs in cold medicine-related Stevens–Johnson syndrome in Thailand
por: Chantaren, Patchima, et al.
Publicado: (2019)

Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing
por: Nakatani, Ken, et al.
Publicado: (2019)

Association of Human Leukocyte Antigen Class 1 genes with Stevens Johnson Syndrome with severe ocular complications in an Indian population
por: Kannabiran, Chitra, et al.
Publicado: (2017)

Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide
por: Vivar, Karina L., et al.
Publicado: (2017)

The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China
por: Yang, Shang-Chen, et al.
Publicado: (2018)

Ampicillin/sulbactam: Stevens-Johnson syndrome/toxic epidermal necrolysis
Publicado: (2021)

Recurrent Steven-Johnson/Toxic Epidermal Necrolysis Overlap Syndrome
por: Toledo-Martinez, Juan F, et al.
Publicado: (2022)

Scoring Assessments in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Dobry, Allison S., et al.
Publicado: (2022)

Aceclofenac induced Stevens-Johnson/toxic epidermal necrolysis overlap syndrome
por: Ameen, Kaderthambi Hajamohideen Nooru, et al.
Publicado: (2013)

Stevens-Johnson syndrome / toxic epidermal necrolysis: an Asia-Pacific perspective
por: Thong, Bernard Yu-Hor
Publicado: (2013)

Stevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin
por: Maciejewska, Jolanta, et al.
Publicado: (2014)

The role of malignancy in the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis
por: Wu, Jennifer, et al.
Publicado: (2014)

New insights in Stevens Johnson syndrome/ toxic epidermal necrolysis syndrome
por: Schroeder, Jan, et al.
Publicado: (2014)

Ibuprofen induced Stevens-Johnson syndrome - toxic epidermal necrolysis in Nepal
por: Angadi, Siddheshwar S, et al.
Publicado: (2016)

Corrigendum to “The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in China”
por: Yang, Shang-Chen, et al.
Publicado: (2018)

Topical moxifloxacin-induced toxic epidermal necrolysis and Stevens-Johnson syndrome
por: Dhavaleshwar, A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q67asg62pu7o8n7pmspif9nhm7